USE OF PROBIOTIC BACTERIAL STRAINS AND CELL EXTRACTS TO INHIBIT ACIDOSIS AND LIVER ABSCESSES IN CATTLE

Natural killer cell containing exogenous mitochondrium and pharmaceutical composition comprising same

MATERIALS AND METHODS FOR TREATING CHRONIC COUGH

Pharmaceutical compositions and uses thereof

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases

Liposomal anticancer compositions

Carmustine pharmaceutical composition

Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy

Antigen capturing nanoparticles for use in cancer immunotherapy

SURFACTANTS AND METHODS FOR MAKING SAME

Antibody formulations

Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same

Adeno-associated virus formulations

Compositions comprising bacterial strains

PYRIMIDINE COMPOUND OR SALT THEREOF IN APPLICATION FOR MANUFACTURING PHARMACEUTICAL PRODUCT FOR PREVENTING AND/OR TREATING FLT3-RELATED DISEASE OR DISORDER

Treatment using dantrolene

FORMULATIONS CONTAINING ACETAMINOPHEN AND SULFOALKYL ETHER CYCLODEXTRIN

Delivery of bioactive, nanoencapsulated antioxidants

Mucoadhesive preparations, methods and applications thereof

Stabilized preparation of interferon beta variant

NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS

Stabilized liquid and lyophilized ADAMTS13 formulations

Use of C-type natriuretic peptide variants to treat osteoarthritis

Compositions comprising bacterial strains

Compositions and methods for treatment

NANOPARTICLE FORMULATIONS AND METHODS OF MAKING AND USING THEREOF

PHARMACEUTICAL PREPARATION FOR DELIVERY OF PEPTIDES AND PROTEINS

NOVEL STABLE FORMULATION

Lyophilized preparation of cytotoxic dipeptides

FORMULATIONS OF POLYALKYLENE OXIDE-ASPARAGINASE AND METHODS OF MAKING AND USING THE SAME

Pharmaceutical preparation treating bone lesions caused by malignant neoplasms

Methods for treatment of diseases

Vaccine delivery systems using yeast cell wall particles

Process for making dry and stable hemostatic compositions

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY AND METHODS OF TREATMENT

REDUCED-VISCOSITY CONCENTRATED PROTEIN FORMULATIONS

Peptide YY pharmaceutical formulations, compositions, and methods

ORAL APPLICATION OF THIOPEPTCIN

Highly concentrated formulations of soluble Fc receptors

Compositions and methods for nanoparticle lyophile forms

METHOD FOR LYOPHILISING AN EXOSOME

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES

Continuous roll-to-roll freeze-drying system and process

Antibodies against factor XI and uses thereof

STERILE INJECTABLE COMPOSITIONS COMPRISING DRUG MICELLES

Therapeutic agent for disc herniation

Manufacture of Degarelix

L-DOPA DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES

Compositions comprising antibody-duocarmycin drug conjugates

Compositions and methods for stabilizing protein-containing formulations

A Novel Method for Stabilization of a Biopharmaceutical Drug Product During Processing

Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof

Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same

Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same

High-pH solid-state epinephrine formulation

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

FVIII Formulation

Carrier-PD-L1 binding agent compositions for treating cancers

Process for producing crystals of a diazabicyclooctane derivative

Composition for oral delivery of bioactive agents

Anti-BAFFR antibody formulations and methods of use thereof

Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6

Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making

COMPOSITION COMPRISING AT LEAST ONE ENZYME AND AT LEAST ONE MICROBICIDAL MOLECULE FOR THE PREVENTION OR TREATMENT OF POST-IMPLANT INFECTIONS

TREATMENT OF DEPRESSION AND PTSD

METHOD OF PRODUCING LEUPROLIDE MICROSPHERE AND USE

Therapeutic microbiota for the treatment and/or prevention of food allergy

Slow Release Pharmaceutical Composition Made of Microparticles

Methods and compositions for CNS delivery of heparan n-sulfatase

Voriconazole inclusion complexes

FREEZE-DRIED FORMULATIONS OF ANTIBACTERIAL PROTEIN

Chloride salt of TAT-NR2B9c

PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR

Active substance of , its use and a composition thereof for improving the reproductive function

Modulation of fat storage in a subject by altering population levels of Christensenellaceae in the GI tract

DRY PLATELET COMPOSITION

Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent

STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE

Methods of treating or preventing stent thrombosis

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF SOMATOSTATIN ANALOGS

Method of preparing lyophilizate of Taheebo alcohol extract

Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drug

Pharmaceutical composition and methods for the prevention and/or treatment of using artificial bacterial colonization

Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drug

BIOACTIVE COMPOUNDS PROTECTION METHOD AND COMPOSITIONS CONTAINING THE SAME

CYCLOHEXENE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND APPLICATION OF SAME

Nanodroplet compositions for the efficient delivery of anti-cancer agents

Dosing regimens for echinocandin class compounds

Notochordal cell matrix as a bioactive lubricant for the osteoarthritic joint

Method of Preparing Solid Dispersions of Active Pharmaceutical Ingredients

PROCESS FOR PREPARING STERILE ARIPIPRAZOLE FORMULATION

Cyclodextrin-panobinostat adduct

Anti-CD40 antibody formulation

Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration

Protein containing tobacco leaf extracts

Methods for culturing and preserving and treating disease and preparation thereof

Stable compositions of pegylated carfilzomib compounds

LYOPHILIZED RECOMBINANT VWF FORMULATIONS

LYOPHILIZED RECOMBINANT VWF FORMULATIONS

Stable anti-neoplastic pharmaceutical composition comprising temozolomide and method of preparing the composition

Sanguisorbigenin polymer micelle and preparative methods thereof

FORMULATIONS OF CHLORAMBUCIL

Multi chamber flexible bag and methods of using same

Lyophilized composition for preserving microbiota in its ecosystem

Compositions comprising bacterial strains

Composition of bacteroides thetaiotaomicron for immune modulation

Compositions and methods for the treatment of allergy

Compositions for fecal floral transplantation and methods for making and using them and device for delivering them

Human tissue derived compositions and uses thereof

Coenzyme Q10 solubilizing composition and method for preparing same

Compositions, methods and uses for thermally stable multi-targeted antigens

Preparation method of azacitidine for injection

Dry powder composition comprising long-chain RNA

Poly (beta-amino esters) and uses thereof

Stable formulations for CNS delivery of arylsulfatase A

Composition composed of ceftriaxone sodium and sulbactum sodium

System and Method for Multiphasic Release of Growth Factors

HGF preparation suitable for treatment of neurological disorders

STABILIZED STATIN FORMULATIONS

PROCESS FOR PREPARING THERAPEUTIC NANOPARTICLES

Pharmaceutical formulation containing gelling agent

Pharmaceutical composition comprising anti-human TSLP receptor antibody

STABILISATION OF POLYPEPTIDES

Compositions and methods for stabilizing alphaviruses with improved formulations

Stabilised Solid Compositions of Factor VII Polypeptides

CARDIAC FIBROBLAST-DERIVED EXTRACELLULAR MATRIX AND INJECTABLE FORMULATIONS THEREOF FOR TREATMENT OF ISCHEMIC DISEASE OR INJURY

Pharmaceutical Formulation Containing Gelling Agent

Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening

Remote loading of sparingly water-soluble drugs into liposomes

Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses

SYSTEMS, METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF ACIDOSIS

Caspofungin Acetate Formulations

Formulations of a PI3K/mTOR-inhibitor for intravenous administration

ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION

Compositions comprising a defined microbiome and methods of use thereof

REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES

Powder formulation having a function of enhancing immunity and method for preparing the same

Long lasting effect of new botulinum toxin formulations

Compositions comprising bacterial strains

STABLE FORMULATIONS FOR LYOPHILIZING THERAPEUTIC PARTICLES

Formulations and methods for lyophilization and lyophilates provided thereby

Pharmaceutical forms of diazabicyclooctane derivatives and process for producing the same

Method of Preparation of SOD Hydrolysates Powder

Drug compound and purification methods thereof

Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS

Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

Composition comprising fine particle and process thereof

COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN

Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer

PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN

COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

Freeze dried drug nanosuspensions

LIPOSOMAL PACLITAXEL PALMITATE FORMULATION AND PREPARATION METHOD THEREOF

PHARMACEUTICAL FORMULATIONS OF TNF-ALPHA ANTIBODIES

Polyomavirus neutralizing antibodies

METHOD FOR PRODUCING EXTRACELLULAR MATRIX MEMBRANE DERIVED FROM BIOCOMPATIBLE PORCINE CARTILAGE CAPABLE OF REGULATING IN VIVO DECOMPOSITION RATE AND PHYSICAL PROPERTIES, AND COMPOSITION FOR PREVENTING ADHESION CONTAINING EXTRACELLULAR MATRIX DERIVED FROM PORCINE CARTILAGE AS ACTIVE INGREDIENT

Radiation - Sterilized Biodegradable Drug Delivery Compositions

De-epoxidized epothilone derivative preparation, preparation of same and use thereof in the treatment of tumor

Pharmaceutical formulation containing gelling agent

Method for vacuum-assisted preservation of biologics including vaccines

Method of lyophilizing liposomes

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

METHOD OF TREATING PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS

STABLE COMPOSITIONS OF PEPTIDE EXPOXY KETONES

USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

Storage stable sincalide formulations

Technology for the Preparation of Microparticles

Biodegradable polymer microsphere compositions for parenteral administration

MRI and CT contrast-enabled composite implants for image-guided tissue regeneration and therapy

NOVEL PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF

FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS

Synthetic platelets

PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS

USE OF NOOTKATONE

Use of polymeric excipients for lyophilization or freezing of particles

Pharmaceutical Preparation Containing Camptothecin-Based Polymeric Derivative

OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS

ADIPOSE TISSUE DERIVED MESENCHYMAL STROMAL CELL CONDITIONED MEDIA AND METHODS OF MAKING AND USING THE SAME

Small molecule agents, compositions, and formulations, for internal use, displaying inhibitory activity against gram-positive and/or gram-negative organisms

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

APO-E MODIFIED LIPID NANOPARTICLES FOR DRUG DELIVERY TO TARGETED TISSUES AND THERAPEUTIC METHODS

Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein

Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them

Compositions and methods for preventing and/or treating vitamin B12 deficiency

BIOACTIVE COMPOUNDS PROTECTION METHOD AND COMPOSITIONS CONTAINING THE SAME

Stable dosage form of etidronate-cytarabine conjugate, and use thereof

Energy recovery in a freeze-drying system

VEGF antagonist formulations suitable for intravitreal administration

Formulation for antibody and drug conjugate thereof

STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS

Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and a method for manufacturing the same

COMPOSITIONS AND METHODS OF USE OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

High surface-area lyophilized compositions comprising arsenic for oral administration in patients

Pharmaceutical composition for prevention or treatment of liver disease

Risperidone sustained release microsphere composition

Formulation and process for modulating wound healing

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

HIGH BIOAVAILABILITY OROMUCOSAL PHARMACEUTICAL PREPARATIONS BASED ON CYCLODEXTRIN AND SUCRALOSE

Bacillus microbial terroir for pathogen control in swine

DRUG DELIVERY COMPOSITIONS AND METHODS

Reconstructed HDL formulation

Anthelmintic compositions and methods

Compositions comprising bacterial strains

Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions

Pharmaceutical compositions comprising phenylaminopyrimidine derivative

Solid forms of bendamustine hydrochloride

Nanoparticles Containing a Taxane and their Use

Pharmaceutical Formulation Containing Gelling Agent

Formulations for treating bladder cancer

Quick dissolving diphenhydramine oral dosage form

Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof

STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

DRUG CONJUGATE COMPOSITION

FORMULATIONS OF ENGINEERED ANTI-IL-10 ANTIBODIES

Composition comprising bacterial strains

METHODS FOR ENHANCED PRODUCTION AND ISOLATION OF CELL-DERIVED VESICLES

A METHOD FOR THE PREPARATION OF A DELIVERY DRUG DELIVERY SYSTEM AND A COMPOSITION THEREFOR

Polyomavirus neutralizing antibodies

Vaccine compositions

Compositions comprising bacterial strains

Drug inclusion complex, preparation thereof, and preparation method thereof

Self-film-forming composition for oral care

Oral preparation and preparation method thereof

Cyclodextrin and antibody-drug conjugate formulations

Fast dissolving pharmaceutical composition

Stabilised Compositions of Factor VII Polypeptides

Compositions comprising bacterial strains

Compositions comprising bacterial strains

Compositions comprising bacterial strains

Drug formulations

Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same

Method of lyophilization of a sample of faecal microbiota

METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT

FORMULATIONS FOR INTRAVENOUS ADMINISTRATION

Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes

PHARMACEUTICAL COMPOSITION AND A METHOD FOR PRODUCING THEREOF

Compositions and methods for stabilization of active agents

Dried saponin liposomal composition

Use of thiosulfate to potentiate the anti-pathogenic effect of lactobacilli

FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES

Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

AMORPHOUS POWDER COMPRISING AN ANGIOTENSIN RECEPTOR BLOCKER AND A NEUTRAL ENDOPEPTIDASE INHIBITOR

ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH REDUCED IMMUNOGENICITY

Probiotic recolonisation therapy

COMPOSITIONS COMPRISING BACTERIAL STRAINS

STABILIZED STATIN FORMULATIONS

Core-shell composite material

PREPARTION OF NANOCRYSTALS AND NANAOPARTICLES OF NARROW DISTRIBUTION AND USES THEREOF

METHOD FOR PREPARING POLYMERIC MICELLE CONTAINING ANIONIC DRUG

Solution preparation containing stabilized antibody

FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS

Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicine

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

Freeze-dried alginic acid preparation

Recombinant human C1 esterase inhibitor and uses thereof

Methods to reduce toxicities and to improve bioavailabilities of nanodrugs

Method for preparing fresh chlorella drink and use of the fresh chlorella drink

Method for the production of freeze-dried pellets comprising factor VIII

Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof

Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use

Sustained-release preparation of poorly soluble drug

Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation

Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration

Vaccine compositions

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

MATERIALS AND METHODS FOR TREATING EMBOLISM

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

Agonist of spexin-based galanin type 2 receptor and use thereof

Composition comprising 2830 (ECGC 13110402)

PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE

PARTICLES, PHARMACEUTICAL PREPARATION, TOPICAL DRUG, AND COSMETIC PRODUCT

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

Formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate

Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease

Amniotic fluid topical formulation

PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR

Disulfiram formulation

Nanoparticle formulations for delivery of nucleic acid complexes

Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules

PROLIPOSOMAL TESTOSTERONE FORMULATIONS

Macrolide particulates, methods for preparation, and medical devices associated therewith

Pharmaceutical compositions of IL-2

Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation

Methods for improving cognition and slowing cognitive impairment using nonviable lyophilized pluripotent stem cells

BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS

Bactericidal and virucidal pharmaceutical composition

Docetaxel and human serum albumin complexes

METHODS OF TREATING INFLAMMATORY BOWEL DISEASE

Stable live attenuated recombinant dengue vaccine

Microbiota restoration therapy (MRT) compositions and methods of manufacture

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

NANOPARTICLE FORMULATIONS AND USES THEREOF

Pharmaceutical composition comprising indole derivatives, process for preparation and use thereof